Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Isabelle Marie

Showing results (101-110 of 136) with videos related to

Pageof 14
Sort By:
Arthritis & Rheumatology (Hoboken, N.J.)|August 12, 2020
Phase II Open Label Study of Anakinra in Intravenous Immunoglobulin-Resistant Kawasaki DiseaseIsabelle Koné-Paut, Stéphanie Tellier, Alexandre Belot, et al.
Rheumatology (Oxford, England)|January 7, 2012
Efficacy and tolerance of infliximab in refractory Takayasu arteritis: French multicentre studyArsène Mekinian, Antoine Néel, Jean Sibilia, et al.
Haematologica|September 5, 2008
Study of the effects of proteasome inhibitors on ribosomal protein S19 (RPS19) mutants, identified in patients with Diamond-Blackfan anemiaAurore Crétien, Corinne Hurtaud, Hélène Moniz, et al.
Diagnostics (Basel, Switzerland)|March 6, 2021
Next-Generation Molecular Investigations in Lysosomal Diseases: Clinical Integration of a Comprehensive Targeted PanelBénédicte Sudrié-Arnaud, Sarah Snanoudj, Ivana Dabaj, et al.
Journal of Clinical Immunology|June 14, 2022
An Immunological Axis Involving Interleukin 1β and Leucine-Rich-α2-Glycoprotein Reflects Therapeutic Response of Children with Kawasaki Disease: Implications from the KAWAKINRA TrialChristoph Kessel, Isabelle Koné-Paut, Stéphanie Tellier, et al.
Ocular Immunology and Inflammation|May 7, 2025
Long-Term Effects of Adalimumab in Juvenile Idiopathic Arthritis-Associated Uveitis: 3- and 6-Year Results of the ADJUVITE TrialYoo-Ri Chung, Delphine Lam, Adam Mainguy, et al.
Rheumatology (Oxford, England)|November 28, 2013
Rituximab for induction and maintenance treatment of ANCA-associated vasculitides: a multicentre retrospective study on 80 patientsPierre Charles, Antoine Néel, Nathalie Tieulié, et al.
Molecular Ecology|October 28, 2022
Genomic profiling of climate adaptation in Aedes aegypti along an altitudinal gradient in Nepal indicates nongradual expansion of the disease vectorIsabelle Marie Kramer, Markus Pfenninger, Barbara Feldmeyer, et al.
Plos One|November 19, 2010
Serum neurotrophin profile in systemic sclerosisMarie-Claude Lise, Agnès Sparsa, Isabelle Marie, et al.
Plos One|November 6, 2015
Efficacy of Rituximab in Refractory Inflammatory Myopathies Associated with Anti- Synthetase Auto-Antibodies: An Open-Label, Phase II TrialYves Allenbach, Marguerite Guiguet, Aude Rigolet, et al.
Pageof 14

Showing results (101-110 of 136) with videos related to

Sort By:
Pageof 14
Arthritis & Rheumatology (Hoboken, N.J.)|August 12, 2020
Phase II Open Label Study of Anakinra in Intravenous Immunoglobulin-Resistant Kawasaki DiseaseIsabelle Koné-Paut, Stéphanie Tellier, Alexandre Belot, et al.
Rheumatology (Oxford, England)|January 7, 2012
Efficacy and tolerance of infliximab in refractory Takayasu arteritis: French multicentre studyArsène Mekinian, Antoine Néel, Jean Sibilia, et al.
Haematologica|September 5, 2008
Study of the effects of proteasome inhibitors on ribosomal protein S19 (RPS19) mutants, identified in patients with Diamond-Blackfan anemiaAurore Crétien, Corinne Hurtaud, Hélène Moniz, et al.
Diagnostics (Basel, Switzerland)|March 6, 2021
Next-Generation Molecular Investigations in Lysosomal Diseases: Clinical Integration of a Comprehensive Targeted PanelBénédicte Sudrié-Arnaud, Sarah Snanoudj, Ivana Dabaj, et al.
Journal of Clinical Immunology|June 14, 2022
An Immunological Axis Involving Interleukin 1β and Leucine-Rich-α2-Glycoprotein Reflects Therapeutic Response of Children with Kawasaki Disease: Implications from the KAWAKINRA TrialChristoph Kessel, Isabelle Koné-Paut, Stéphanie Tellier, et al.
Ocular Immunology and Inflammation|May 7, 2025
Long-Term Effects of Adalimumab in Juvenile Idiopathic Arthritis-Associated Uveitis: 3- and 6-Year Results of the ADJUVITE TrialYoo-Ri Chung, Delphine Lam, Adam Mainguy, et al.
Rheumatology (Oxford, England)|November 28, 2013
Rituximab for induction and maintenance treatment of ANCA-associated vasculitides: a multicentre retrospective study on 80 patientsPierre Charles, Antoine Néel, Nathalie Tieulié, et al.
Molecular Ecology|October 28, 2022
Genomic profiling of climate adaptation in Aedes aegypti along an altitudinal gradient in Nepal indicates nongradual expansion of the disease vectorIsabelle Marie Kramer, Markus Pfenninger, Barbara Feldmeyer, et al.
Plos One|November 19, 2010
Serum neurotrophin profile in systemic sclerosisMarie-Claude Lise, Agnès Sparsa, Isabelle Marie, et al.
Plos One|November 6, 2015
Efficacy of Rituximab in Refractory Inflammatory Myopathies Associated with Anti- Synthetase Auto-Antibodies: An Open-Label, Phase II TrialYves Allenbach, Marguerite Guiguet, Aude Rigolet, et al.
Pageof 14